Earnings History Data for KemPharm, Inc. (KMPH) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

KemPharm, Inc.

KemPharm Inc. is a specialty pharmaceutical company which is engaged in the discovery and development of new molecular entity prodrugs. Its product candidates include KP201/APAP, KP511/ER and KP606/ER for the treatment of pain; KP415 for the treatment of attention deficit hyperactivity disorder and KP303 for the treatment of central nervous system disorders, which are in preclinical trail stage. The Company through its LAT platform technology generate prodrug. KemPharm Inc. is based in CORALVILLE, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
09-11-2022	AH	4:05 PM ET (Nov 9)	KMPH	KemPharm, Inc.	192.82	-0.19	-0.19	-0.06	KemPharm GAAP EPS of -$0.19 misses by $0.03, revenue of $2.87M misses by $0.14M [11/9/2022 4:19 PM]	4.60	-0.76 (-14.18%)	5.13	-0.23 (-4.29%)	4.00 - 9.69	831,832	110,000	2,560
KemPharm GAAP EPS of -$0.19 misses by $0.03, revenue of $2.87M misses by $0.14M [11/9/2022 4:19 PM] KemPharm down 5% after Q3 results miss on both lines [11/9/2022 5:26 PM] KemPharm Reports Third Quarter 2022 Results [Nov-09-22 04:05PM]
11-08-2022	AH	4:05 PM ET (Aug 11)	KMPH	KemPharm, Inc.	184.17	-0.19	-0.14	-0.40	KemPharm Non-GAAP EPS of -$0.19 misses by $0.05, revenue of $1.3M misses by $0.45M [8/11/2022 4:17 PM]	6.11	-0.07 (-1.13%)	6.00	-0.18 (-2.91%)	4.00 - 10.80	354,522	330,000	16,105
KemPharm Non-GAAP EPS of -$0.19 misses by $0.05, revenue of $1.3M misses by $0.45M [8/11/2022 4:17 PM] KemPharm Reports Second Quarter 2022 Financial Results and Corporate Updates [Aug-11-22 04:05PM] KemPharm, Inc. (NASDAQ:KMPH) Is Expected To Breakeven In The Near Future [Aug-11-22 08:53AM]
12-05-2022	AH	4:05 PM ET (May 12)	KMPH	KemPharm, Inc.	149.74	-0.06	-0.05	-1.61	KemPharm GAAP EPS of -$0.05 beats by $0.01, revenue of $4M beats by $0.94M [5/12/2022 4:16 PM]	4.10	-0.14 (-3.30%)	4.13	-0.11 (-2.59%)	4.00 - 15.70	404,998	570,000	10,080
KemPharm GAAP EPS of -$0.05 beats by $0.01, revenue of $4M beats by $0.94M [5/12/2022 4:16 PM] KemPharm to Present at Multiple Upcoming Investor Conferences [May-11-22 07:30AM] KemPharm Reports First Quarter 2022 Financial Results and Corporate Updates [May-12-22 04:05PM]
30-03-2022	AH	4:05 PM ET (Mar 30)	KMPH	KemPharm, Inc.	178.53	N/A	-0.08	0.00	KemPharm GAAP EPS of -$0.08, revenue of $2.6M [3/30/2022 4:20 PM]	5.05	-0.27 (-5.08%)	5.15	-0.17 (-3.20%)	4.89 - 15.70	838,402	490,000	1,106
KemPharm GAAP EPS of -$0.08, revenue of $2.6M [3/30/2022 4:20 PM] KemPharm Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Corporate Updates [Mar-30-22 04:05PM]
10-11-2021	AH	4:05 PM ET (Nov 10)	KMPH	KemPharm, Inc.	332.55	-0.06	-0.08	-0.64	KemPharm EPS beats by $0.02, misses on revenue [11/10/2021 4:10 PM]	9.35	0.25 (2.75%)	9.47	0.37 (4.07%)	5.08 - 22.08	225,544	360,000	4,040
KemPharm EPS beats by $0.02, misses on revenue [11/10/2021 4:10 PM] KemPharm Reports Third Quarter 2021 Financial Results and Corporate Updates [Nov-10-21 04:05PM]
12-08-2021	AH	4:05 PM ET (Aug 12)	KMPH	KemPharm, Inc.	346.74	-0.40	0.22	0.16	KemPharm EPS misses by $0.63, misses on revenue [8/12/2021 4:20 PM]	9.08	-1.11 (-10.89%)	9.27	-0.92 (-9.03%)	5.08 - 22.08	1,504,413	400,000	52,607
KemPharm EPS misses by $0.63, misses on revenue [8/12/2021 4:20 PM] KemPharm Reports Second Quarter 2021 Financial Results [Aug-12-21 04:05PM]
13-05-2021	AH	4:05 PM ET (May 13)	KMPH	KemPharm, Inc.	248.71	-1.61	-0.17	-1.60	KemPharm EPS misses by $0.37, beats on revenue [5/13/2021 4:24 PM]	9.09	0.57 (6.69%)	8.65	0.13 (1.53%)	1.94 - 22.08	879,163	610,000	2,702
KemPharm EPS misses by $0.37, beats on revenue [5/13/2021 4:24 PM] KemPharm, Inc. to Host Earnings Call [May-13-21 02:30PM] KemPharm Reports First Quarter 2021 Financial Results [May-13-21 04:05PM]
11-03-2021	AH	4:05 PM ET (Mar 11)	KMPH	Kempharm, Inc.	170.00	N/A	-0.67	0.00	KemPharm EPS misses by $0.40, beats on revenue [3/11/2021 6:01 PM]	9.39	-0.59 (-5.91%)	9.29	-0.69 (-6.91%)	1.94 - 22.08	3,831,444	10,918,959	254,562
KemPharm EPS misses by $0.40, beats on revenue [3/11/2021 6:01 PM] KemPharm, Inc. to Host Earnings Call [Mar-11-21 02:30PM] KemPharm Reports Fourth Quarter and Full-Year 2020 Financial Results [Mar-11-21 04:25PM]
29-10-2020	AH	4:05 PM ET (Oct 29)	KMPH	Kempharm, Inc.	44.00	-0.64	-0.05	0.00	KemPharm EPS beats by $0.01, revenue in-line [10/29/2020 4:34 PM]	0.5551	-0.05 (-7.64%)	0.0	0.0 (0.00%)	0.12 - 0.92	411,945	0	0